Opportunity Radar

← Back to search

Grant forecast

Expanded Surveillance for Pediatric Infectious Diseases

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
CA
Agency
Centers for Disease Control and Prevention - ERA
Sub-agency
HHS-CDC-HHSCDCERA
Solicitation #
RFA-IP-27-035
Posted
Jul 28, 2026
Response due
Dec 31, 2026
Archive date
Jan 30, 2027
CFDA / Assistance listing
93.083
Award floor
$850,000
Award ceiling
$1,140,000
Total program funding
$40,000,000
Contact
Jamal Bankhead · JBankhead@cdc.gov · 404-718-4108
Source
Grants.gov

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.Component A – Core Component (Required)Support inpatient and emergency department pediatric surveillanceFollow the standardized protocol established by CDCOptional ComponentsComponent B: Support outpatient pediatric surveillanceComponent C: Study immune response and infectionComponent D: Study immune response and immunizationRecipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.Findings of this NOFO will:Improve best practices for diagnosis and treatment protocolsInform prevention product recommendationsGuide public health strategiesReduce viral illness-associated hospitalizations and healthcare utilization among children

Similar open opportunities

Grant forecast

DHQP Global NOFO

Centers for Disease Control - NCEZID · HHS-CDC-NCEZID

Due
May 20, 2027 (184d)
Posted
Aug 3, 2026